High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.
Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P.
Galasko D, et al. Among authors: thomas r.
Arch Neurol. 1998 Jul;55(7):937-45. doi: 10.1001/archneur.55.7.937.
Arch Neurol. 1998.
PMID: 9678311
Clinical Trial.